Morningstar Investor users sign in here.

Company Profile

  • Business description

    Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

  • Contact

    1851 Harbor Bay Parkway
    Alameda CA 94502
    USA

    T: +1 650 837-7000

    E: shubbard@exelixis.com

    https://www.exelixis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    1,310

Exelixis Inc News & Analysis

stocks

9 mid-cap stocks for your US pick list

Clothing retailer Gap, brewer Molson Coors and Exelixis, which develops kidney and liver cancer treatments, are among recent additions to Morningstar's list of mid-sized US companies trading at attractive prices.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,076.90 101.80 1.28%
CAC 40 7,662.30 44.59 -0.58%
DAX 40 18,177.62 147.96 -0.81%
Dow JONES (US) 39,074.96 75.37 -0.19%
FTSE 100 8,247.79 33.76 -0.41%
HKSE 18,072.90 45.19 0.25%
NASDAQ 17,676.15 13.21 -0.07%
Nikkei 225 39,173.15 368.50 0.95%
NZX 50 Index 11,716.44 88.58 0.76%
S&P 500 5,457.14 9.27 0.17%
S&P/ASX 200 7,838.80 105.10 1.36%
SSE Composite Index 2,950.00 13.10 -0.44%

Market Movers

Name
Last price
Change
% Change
Red 5 Ltd RED 0.39 0.03 -6.10%
Core Lithium Ltd CXO 0.09 0.01 8.86%
Lake Resources NL LKE 0.04 0.00 -4.55%
Sayona Mining Ltd SYA 0.04 0.00 2.94%
Telstra Group Ltd TLS 3.63 0.01 0.28%
Pilbara Minerals Ltd PLS 3.15 0.04 1.29%
Imugene Ltd IMU 0.06 0.00 3.64%
Liontown Resources Ltd LTR 0.90 0.01 -1.10%
Melbana Energy Ltd MAY 0.05 0.01 20.00%
Botanix Pharmaceuticals Ltd BOT 0.37 0.01 -2.67%